As of 2024-12-12, the Fair Value of Mirum Pharmaceuticals Inc (MIRM) is -10.40 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 43.61 USD, the upside of Mirum Pharmaceuticals Inc is -123.84%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -52.55 | -103.27 | -83.99 | -135.67 | -163.41 | -107.78 |
| YoY growth | -202.88% | -96.52% | 18.67% | -61.53% | -20.45% | -72.54% |
| Market Cap (mil) | 2,093.28 |
| P/E | |
| Forward P/E |
| EPS | -2.08 |
| Avg earnings growth rate | -72.54% |
| TTM earnings | -99.81 |